Hegde Priti
Insider CIK 1880034 · ADAP Director · TCRR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-07-01 | 2024-07-01 | 1,144,686 | — | $0 | 1,144,686 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-05 | 2023-07-05 | 152,376 | — | $0 | 152,376 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-05 | 2023-07-05 | 109,746 | — | $0 | 109,746 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-05 | 2023-07-05 | 226,464 | — | $0 | 226,464 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-03 | 2023-07-03 | 500,000 | — | $0 | 500,000 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,100 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 24,968 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 16,800 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-12-15 | 2022-12-19 | 16,800 | — | $0 | 16,800 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2021-12-09 | 2021-12-10 | 12,100 | — | $0 | 12,100 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2021-08-25 | 2021-08-26 | 24,968 | — | $0 | 24,968 | SEC↗ |